Browse articles from EyeWorld.org related to glaucoma. EyeWorld is the award-winning member publication of ASCRS. The magazine provides news and updates from the Society as well as clinical features in the areas of cataract, refractive, cornea, glaucoma, and practice management. It publishes quarterly with editorial direction from its medical editorial board and staff.
➤ Study: 1-year results with IOP-lowering implant ➤ Phase 2 study of investigational dry eye treatment nears enrollment target ➤ Study identifies antibody that could lead to retinitis pigmentosa treatment ➤ Gene therapy for inherited optic neuropathy approved for clinical trials ➤ ASCRS news and events
➤ FDA issues complete response letter for bevacizumab for retinal diseases ➤ First patient dosed in study evaluating X-linked retinoschisis ➤ Gene therapy study for Leber hereditary optic neuropathy begins dosing ➤ Update on rare retinal vasculitis events associated with GA treatment ➤ Eye drop recall grows ➤ ASCRS news and events
➤ FDA approves high-dose aflibercept ➤ Positive results in Phase 1 trial for cultivated autologous limbal epithelial cells ➤ Study: data from eye scans detect Parkinson’s disease years before clinical presentation ➤ Phase 2/3 study to evaluate persistent corneal epithelial defect treatment ➤ Phase 3 study offers results with aflibercept biosimilar ➤ ASCRS news and events
“Best practices are the summation of the technical aspects of medicine. They are, in effect, the perfection of the form of medicine,” said Julie Schallhorn, MD. She shared this and other thoughts on best practices and gave a preview of the articles in the Cornea section of the issue.
“The ASCRS Annual Meeting’s glaucoma programming and scientific content … shows me that while we have a long road ahead of us, the creativity, collaboration, and connectedness that exemplify ASCRS will help us light the way,” said Manjool Shah, MD. He shared what to expect in the Glaucoma section of the issue.
➤ FDA approves first treatment targeting Demodex ➤ Phase 1 study compares mechanical dry eye treatment to drop therapy ➤ Topical gene therapy for rare ocular surface condition ➤ Glaucoma drug licensed for commercialization in U.S. ➤ ASCRS news and events
Optimizing ocular conditions prior to surgery is standard for any procedure, but eyes with glaucoma present extra considerations. EyeWorld spoke with two ophthalmologists to get insights on how to prepare eyes with glaucoma for different ocular procedures. They also shared a few intraoperative and postop considerations along the way.
This article recaps the 2023 Richard L. Lindstrom, MD, Lecture, titled “Glaucoma Surgery: Taking it to the Next Level,” given by Marlene Moster, MD, as well as the other presentations in the session, given by Cathleen McCabe, MD, Francis Mah, MD, and Daniel Chang, MD.
Creating an effective treatment plan for a patient with uveitic glaucoma requires the ophthalmologist to consider and balance evolving, multiple, and sometimes competing disease processes. Several physicians discussed what to look for and how to manage and treat these patients.
➤ Phase 1/2 trial to evaluate intravitreal implant to delay cataract progression ➤ Update from Phase 1/2 proof-of-concept trial for chronic TED treatment ➤ First patient dosed for investigational, oral geographic atrophy treatment ➤ Pediatric study for pain, inflammation treatment following ocular surgery ➤ Complimentary access to video journal ➤ ASCRS news and events